featured
Aromatase Inhibitors vs Tamoxifen in Premenopausal Women With ER+ Early-Stage Breast Cancer Treated With Ovarian Suppression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology